Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties-Reference-Cited by-同舟云学术

Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties

Published:2021-01-21 Issue:3 Volume:18 Page:966-975
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Iikuni Shimpei¹^ORCID,Okada Yuya¹,Shimizu Yoichi¹²,Watanabe Hiroyuki¹^ORCID,Ono Masahiro¹^ORCID

Affiliation:

1. Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan

2. Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

Funder

Japan Agency for Medical Research and Development

Nihon Medi-Physics Co., Ltd.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00953

Reference36 articles.

1. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

2. Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression